abkbiomedical.com Report : Visit Site

Technical data of the abkbiomedical.com

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host abkbiomedical.com. Currently, hosted in United States and its service provider is Weebly Inc. .

the related websites

photopendant.co.uk uffordwhitelion.co.uk tidburygreen-pc.org.uk rococosystems.com ukgamefair.co.uk interventionalnews.com 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called Apache containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

who we are board of directors clinical advisory board radiopacity products investors news & events contact ' + ' \x3c/script ' + ' ' + ' ' + ' '; settimeout(function() { var videoiframe414055476140853746actual = document.getelementbyid("video-iframe-414055476140853746").contentdocument; videoiframe414055476140853746actual.open().write(videoiframe414055476140853746content); videoiframe414055476140853746actual.close(); }, 500); abk biomedical inc. innovative embolic therapies. affiliations historical events and news acoa announces $3m in support for abk biomedical's manufacturing scale-up of easi-vue embolization microspheres february 22, 2018, halifax, canada see news and events for more details. sir2017 - 42nd annual scientific meeting march 4 - 9, 2017, washington, dc join abk biomedical as they present their studies entitled " multi-modal "imageable" embolic microspheres: a preliminary study on occlusion effectiveness, level of occlusion and arterial distribution in a swine liver model ” at the walter e. washington convention centre during the scientific session in room 143c on march 5th from 3.00pm to 4.30pm. see http://www.sirmeeting.org for more details. abk biomedical featured in interventional oncology 360° may 30, 2016, halifax, canada abk's lead technology (occlusystem) is featured on the interventional oncology 360 ° e-news site. writer jennifer ford interviewed abks ceo dr bob abraham on the results from the large glp study of imageable embolic microspheres (iems) performed in a swine renal artery embolization model. view a video of the interview here . sir2016 - 41st annual scientific meeting april 2 - 7, 2017, vancouver, bc, canada join abk biomedical as they present their studies entitled " a bilateral partial swine renal artery embolization study using “imageable” embolic microspheres: assessment of mechanism of occlusion, embolization effectiveness, device migration and safety ” at the vancouver convention centre during the scientific session in room 203/204 on april 5th from 3.00pm to 4.30pm. see http://www.sirmeeting.org for more details. sir2015 - 40th annual scientific meeting february 28 - march 5, 2015, atlanta, ga, us join abk biomedical as they present their studies entitled "unilateral renal artery embolization in yucutan miniswine with imageable embolic microspheres" and "magnetic resonance imaging characteristics of imageable embolic microspheres” at the georgia world congress centre from february 28th to march 5th, 2015. see http://www.sirmeeting.org for more details. enginuitymed delivers ‘on the doorstep’ development for abk biomedical november 4, 2014, halifax, canada abk biomedical engages enginuitymed to deliver engineering support for their occlusystem delivery device. abk biomedical attracts world leaders to clinical advisory board october 15, 2014, halifax, canada abk biomedical inc., announced today the appointment of three leading experts in interventional radiology to its clinical advisory board. more great press on abk’s ceo october 3, 2014, halifax, canada abk's ceo is profiled today in the all nova scotia on line news site. writer devin stevens interviewed dr bob abraham on the consolidation of abk operations to halifax and the next steps to occlusystem regulatory approval. and another great article on entrevestor.com: http://entrevestor.com/blog/abk-names-abraham-ceo1 . abk biomedical expands halifax operations with appointment of new ceo october 2, 2014, halifax, canada abk biomedical inc., announced today it is consolidating its operations to halifax. heading up this consolidation will be abk biomedical’s new chief executive officer, dr. bob abraham. esb 2014 - 26th european conference on biomaterials august 31 - september 3, 2014, liverpool, uk the esb conference will bring together experts and scientists from academia and industry, and also those involved in funding regulatory and commercial enterprises related to biomaterials science, tissue engineering and regenerative medicine. see http://www.esb2014.org for more details. cirse 2014 - 30th annual cardiovascular interventional radiology society in europe congress september 13 - 17, glasgow, uk the cirse annual congress has become the leading european platform for interventionists. see http://www.cirse.org for more details. see more events... abk biomedical inc. provides and continues to provide accurate information on its website. however, abk biomedical inc. assumes no responsibility for accuracy and/or completeness, express or implied, as to the information contained or omitted and/or the products described. furthermore, abk biomedical may change the products mentioned at any time without notice. at this time, abk biomedical inc. products are not intended or approved for clinical use. ​ (c) copyright 2016 - all international rights reserved - abk biomedical inc.

URL analysis for abkbiomedical.com

http://www.abkbiomedical.com/investors.html
http://www.abkbiomedical.com/radiopacity.html
http://www.abkbiomedical.com/contact.html
http://www.abkbiomedical.com/clinical-advisory-board.html
http://www.abkbiomedical.com/news--events.html
http://www.abkbiomedical.com/products.html
http://www.abkbiomedical.com/who-we-are.html
http://www.abkbiomedical.com/board-of-directors.html
http://www.abkbiomedical.com/news--events

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: ABKBIOMEDICAL.COM
Registry Domain ID: 1708228465_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.rebel.ca
Registrar URL: http://www.rebel.ca
Updated Date: 2018-03-22T07:46:35Z
Creation Date: 2012-03-21T15:41:09Z
Registry Expiry Date: 2019-03-21T15:41:09Z
Registrar: Rebel.ca Corp.
Registrar IANA ID: 735
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: 1-866-620-7111
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS1.BYETHOST20.ORG
Name Server: NS2.BYETHOST20.ORG
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2018-07-15T09:29:06Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.

  REGISTRAR Rebel.ca Corp.

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =abkbiomedical.com

  PORT 43

  TYPE domain

DOMAIN

  NAME abkbiomedical.com

  CHANGED 2018-03-22

  CREATED 2012-03-21

STATUS
clientTransferProhibited https://icann.org/epp#clientTransferProhibited
clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited

NSERVER

  NS1.BYETHOST20.ORG 31.22.4.73

  NS2.BYETHOST20.ORG 31.22.4.72

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .